Glomerular diseases in COVID-19
Su H , et al.. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int 2020; 98:219–227. doi: 10.1016/j.kint.2020.04.003
Farkash EA , et al.. Ultrastructural evidence for direct renal infection with SARS-CoV-2. J Am Soc Nephrol 2020; 31:1683−1687. doi: 10.1681/ASN.2020040432
Calomeni E , et al.. Multivesicular bodies mimicking SARS-CoV-2 in patients without COVID-19. Kidney Int 2020; 98:233–234. doi: 10.1016/j.kint.2020.05.003
Smith KD , et al.. Am I a coronavirus? Kidney Int 2020; 98:506–507. doi: 10.1016/j.kint.2020.05.021
Puelles VG , et al.. Multiorgan and renal tropism of SARS-CoV-2. N Engl J Med 2020; 383:590−592. doi: 10.1056/NEJMc2011400
Sharma P , et al.. COVID-19-associated kidney injury: A case series of kidney biopsy findings. J Am Soc Nephrol 2020; 31:1948–1958. doi: 10.1681/ASN.2020050699
Golmai P , et al.. Histopathologic and ultrastructural findings in postmortem kidney biopsy material in 12 patients with AKI and COVID-19. J Am Soc Nephrol 2020; 31:1944–1947. doi: 10.1681/ASN.2020050683
Santoriello D , et al.. Postmortem kidney pathology findings in patients with COVID-19. J Am Soc Nephrol 2020; 31:2158–2167. doi: 10.1681/ASN.2020050744
Kudose S , et al.. Kidney biopsy findings in patients with COVID-19. J Am Soc Nephrol 2020; 31:1959–1968. doi: 10.1681/ASN.2020060802
Wu H , et al.. AKI and collapsing glomerulopathy associated with COVID-19 and APOL1 high-risk genotype. J Am Soc Nephrol 2020; 31:1688–1695. doi: 10.1681/ASN.2020050558
Sharma P , et al.. Pathology of COVID 19 associated acute kidney injury. Clin Kidney J [published online ahead of print January 24, 2021]. https://academic.oup.com/ckj/advance-article/doi/10.1093/ckj/sfab003/6118199
Nasr SH , et al.. Kidney biopsy findings in patients with COVID-19, kidney injury, and proteinuria. Am J Kidney Dis 2021; 77:465−468. doi: 10.1053/j.ajkd.2020.11.002
Nichols B , et al.. Innate immunity pathways regulate the nephropathy gene apolipoprotein L1. Kidney Int 2015; 87:332−342. doi: 10.1038/ki.2014.270
Velez JCQ , et al.. COVAN is the new HIVAN: The re-emergence of collapsing glomerulopathy with COVID-19. Nat Rev Nephrol 2020; 16:565–567. doi: 10.1038/s41581-020-0332-3
Yamada M , et al.. Minimal change disease with nephrotic syndrome associated with coronavirus disease 2019 after apolipoprotein L1 risk variant kidney transplant: A case report. Transplant Proc 2020; 52:2693–2697. doi: 10.1016/j.transproceed.2020.08.012
Fousert E , et al.. Neutrophil extracellular traps (NETs) take the central stage in driving autoimmune responses. Cells 2020; 9:915. doi: 10.3390/cells9040915
Akilesh S , et al.. Multicenter clinicopathologic correlation of kidney biopsies performed in COVID-19 patients presenting with acute kidney injury or proteinuria. Am J Kidney Dis 2021; 77:82–93.e1. doi: 10.1053/j.ajkd.2020.10.001
Jhaveri KD , et al.. Thrombotic microangiopathy in a patient with COVID-19. Kidney Int 2020; 98:509–512. doi: 10.1016/j.kint.2020.05.025
Perico L , et al.. Immunity, endothelial injury and complement-induced coagulopathy in COVID-19. Nat Rev Nephrol 2021; 17:46–64. doi: 10.1038/s41581-020-00357-4
Fontana F , et al.. Oxalate nephropathy caused by excessive vitamin C administration in 2 patients with COVID-19. Kidney Int Rep 2020; 5:1815−1822. doi: 10.1016/j.ekir.2020.07.008
Bomback AS , et al.. How COVID-19 has changed the management of glomerular diseases. Clin J Am Soc Nephrol 2020; 15:876–879. doi: 10.2215/CJN.04530420